Skip to content

Research on Novel Strategies for Total Three-Dimensional Guided Atrial Fibrillation Ablation

Research on Novel Strategies for Total Three-Dimensional Guided Atrial Fibrillation Ablation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098061
Enrollment
Unknown
Registered
2025-03-03
Start date
2025-03-07
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Atrial Fibrillation

Interventions

High-risk group with adjunctive right atrial ablation:Circumferential pulmonary vein isolation combined with right atrial regional homogenization ablation
High-risk group with left atrial ablation only:Circumferential pulmonary vein isolation
Low-risk group with left atrial ablation only:Circumferential pulmonary vein isolation

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Meets the indications for catheter ablation in atrial fibrillation 2: Patients aged 18-80 years 3: Patients with non-paroxysmal atrial fibrillation (AF); non-paroxysmal AF is defined as sustained episodes lasting >7 days 4: Sign the informed consent form and receive the necessary follow-up

Exclusion criteria

Exclusion criteria: 1) Abnormal coagulation function or anticoagulation contraindications; 2) Abnormal coagulation function or anticoagulation contraindications; 3) Left anteroposterior diameter >=55mm; 4) left atrial thrombus; 5) Severe structural heart disease (severe mitral regurgitation, hypertrophic cardiomyopathy, dilated cardiomyopathy, etc.); 6) Abnormal thyroid function; 7) Severe hepatic and renal insufficiency (AST or ALT>3 times the upper limit; Scr>3.5mg/dl or Ccr<30ml/min)

Design outcomes

Primary

MeasureTime frame
Atrial tachyarrhythmia recurrence rate;

Secondary

MeasureTime frame
Acute successful rate;Short-term complications;

Countries

China

Contacts

Public ContactRonghui Yu

The First Affiliated Hospital of Anhui Medical University

ronghuiyu@vip.sina.com+86 139 0108 0383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026